Cited time in webofscience Cited time in scopus

Full metadata record

DC Field Value Language
dc.contributor.author Teo, Ruijie D. -
dc.contributor.author Hwang, Jae Youn -
dc.contributor.author Termini, John -
dc.contributor.author Gross, Zeev -
dc.contributor.author Gray, Harry B. -
dc.date.available 2017-08-10T08:17:17Z -
dc.date.created 2017-08-09 -
dc.date.issued 2017-02 -
dc.identifier.issn 0009-2665 -
dc.identifier.uri http://hdl.handle.net/20.500.11750/4236 -
dc.description.abstract Corroles are exceptionally promising platforms for the development of agents for simultaneous cancer-targeting imaging and therapy. Depending on the element chelated by the corrole, these theranostic agents may be tuned primarily for diagnostic or therapeutic function. Versatile synthetic methodologies allow for the preparation of amphipolar derivatives, which form stable noncovalent conjugates with targeting biomolecules. These conjugates can be engineered for imaging and targeting as well as therapeutic function within one theranostic. assembly. In this review, we begin with a brief outline of corrole chemistry that has been uniquely useful in designing corrole-based anticancer agents. Then we turn attention to the early literature regarding corrole anticancer activity, which commenced one year after the first scalable synthesis was reported (1999-2000). In 2001, a major advance was made with the introduction of negatively charged corroles, as these molecules, being amphipolar, form stable conjugates with many proteins. More recently, both cellular uptake and intracellular trafficking of metallocorroles have been documented in experimental investigations employing advanced optical spectroscopic as well as magnetic resonance imaging techniques. Key results from work on both cellular and animal models are reviewed, with emphasis on those that have shed new light on the mechanisms associated with anticancer activity. In closing, we predict a very bright future for corrole anticancer research, as it is experiencing exponential growth, taking full advantage of recently developed imaging and therapeutic modalities. -
dc.language English -
dc.publisher American Chemical Society -
dc.title Fighting Cancer with Corroles -
dc.type Article -
dc.identifier.doi 10.1021/acs.chemrev.6b00400 -
dc.identifier.scopusid 2-s2.0-85013485316 -
dc.identifier.bibliographicCitation Chemical Reviews, v.117, no.4, pp.2711 - 2729 -
dc.description.isOpenAccess FALSE -
dc.subject.keywordPlus Amphiphilic Corroles -
dc.subject.keywordPlus Anti Cancer Activity -
dc.subject.keywordPlus Biological Activities -
dc.subject.keywordPlus Cellular Uptake -
dc.subject.keywordPlus Combination Therapy -
dc.subject.keywordPlus Free Base Corroles -
dc.subject.keywordPlus Gold(III) Porphyrins -
dc.subject.keywordPlus In Vivo -
dc.subject.keywordPlus Photodynamic Therapy (PDT) -
dc.subject.keywordPlus Photophysical Properties -
dc.citation.endPage 2729 -
dc.citation.number 4 -
dc.citation.startPage 2711 -
dc.citation.title Chemical Reviews -
dc.citation.volume 117 -
Files in This Item:

There are no files associated with this item.

Appears in Collections:
Department of Electrical Engineering and Computer Science MBIS(Multimodal Biomedical Imaging and System) Laboratory 1. Journal Articles

qrcode

  • twitter
  • facebook
  • mendeley

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE